Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasive Lobular Carcinoma of the Breast
Serial ctDNA testing in patients with mILC is feasible and may enable personalized surveillance and real-time therapeutic monitoring.
Authors
- Steffi Oesterreich (ORCID: https://orcid.org/0000-0002-2537-6923)
- Julia Foldi (ORCID: https://orcid.org/0000-0002-7504-867X)
- Samuel Rivero-Hinojosa
- Minetta C. Liu (ORCID: https://orcid.org/0000-0002-8206-5232)
- Adrian V. Lee (ORCID: https://orcid.org/0000-0001-9917-514X)
- Jenifer Ferguson
- Ekaterina Kalashnikova (ORCID: https://orcid.org/0000-0003-1078-0656)
- Angel Rodriguez (ORCID: https://orcid.org/0000-0003-0735-3039)
- Antony Tin (ORCID: https://orcid.org/0009-0007-1602-2123)
- Janie Fielder
Institutions
- University of Pittsburgh (US)
- Magee-Womens Research Institute (US)
- Natera (United States) (US)
- UPMC Hillman Cancer Center (US)
Publication Details
- Journal
- JCO Precision Oncology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1200/po-24-00577
- Citations
- 6
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 5.62